Home >  Registry
     
 
Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Trial information

Viral Associated Hepatitis Study

Status: Completed

Protocol number: H1-1860-25750-01

Company division: Diagnostic

Official Scientific Title: Viral associated hepatitis study

Brief summary: This study is designed to identify potentially significant variables of HCV progression over time, including demographics, lifestyle, liver injury markers, viral load, coinfection with other viruses, and severity of initial liver histology.

Study type: Interventional; Non-Randomized; Open Label; Uncontrolled; Single Group study

Condition: Hepatitis C, Chronic

Intervention type: Diagnostic Test

Intervention name: AMPLICOR GT HCV MONITOR v2.0

Inclusion criteria:

  • 18-100 years of age;
  • hepatitis C antibody positive
  • Exclusion criteria: None specified

    Gender: Males or Females

    Age limits: Min: 18 Years Max: 100 Years

    Anticipated start date: January, 2006

    Trial registration date: 03/16/2006

    Date last updated: 9/29/2008


    Link to trial result

    This trial was conducted at the following locations:

    United States

    • San Francisco, CA

    To contact Roche for more information on this trial please complete the email form below. Treatment decisions and/or suitability for a specific trial are decisions only your healthcare provider can make. If you are patient interested in any of the studies, please have your healthcare provider contact us via this website, and they will be provided with the relevant clinical trial information.

    Country*
    Are you a:*
    Subject*
    Last Name*
    First Name*
    Telephone
    E-mail*

    your email address is needed for us to reply